| Literature DB >> 31538120 |
Rathapon Asasutjarit1, Tunradee Meesomboon1, Pheeraphong Adulheem1, Siriporn Kittiwisut2, Papawee Sookdee3, Worada Samosornsuk4, Asira Fuongfuchat5.
Abstract
HYPOTHESIS: Alpha-mangostin (AMG) is a natural compound possessing strong antibacterial activity. Because of its poor water solubility, the formulations of AMG usually require high concentrations of solubilizers leading limitation for using in some clinical applications. Thus, the novel formulation of topical nanoemulsion (NE) containing AMG (AMG-NE) with optimal content of the oil phase and surfactants was developed. EXPERIMENTS: AMG was extracted, purified and used as an active ingredient of AMG-NE. Blank NEs (NEs without AMG) with varying in contents of the oil phase and surfactants and AMG-NE were prepared by the ultrasonication technique. They were investigated their physicochemical properties including antibacterial activity against Staphyloccocus aureus and Propionibacterium acnes (which is recently renamed as Cutibacterium acnes).Entities:
Keywords: Acnes vulgaris; Alpha-mangostin; Antibacterial activity; Formulation; Infectious disease; Mangoteen pericarps extract; Materials application; Materials safety; Nanoemulsion; Nanomaterials; Pharmaceutical chemistry; Pharmacology; Physical chemistry; Physicochemical properties; Skin toxicity; Transdermal drug delivery; Ultrasonication
Year: 2019 PMID: 31538120 PMCID: PMC6745438 DOI: 10.1016/j.heliyon.2019.e02465
Source DB: PubMed Journal: Heliyon ISSN: 2405-8440
Summary of formulation compositions of Blank NEs, AMG-NE and their physicochemical properties (mean ± SD; n = 3).
| Formulations | Concentrations (%w/w) | AMG (%w/w) | Droplet size | PI | Zeta potential (mV) | pH | EE | LC | Phase separation | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mixed oil | Mixed surfactant | (%) | (%) | |||||||
| 5MO-8MS | 5 | 8 | 0 | 183 ± 86 | 0.22 ± 0.03 | -2.4 ± 0.3 | 5.8 ± 0.1 | - | - | Not found |
| 10MO-8MS | 10 | 8 | 0 | 212 ± 124 | 0.34 ± 0.02 | -5.8 ± 0.2 | 5.6 ± 0.1 | - | - | Not found |
| 15MO-8MS | 15 | 8 | 0 | 302 ± 217 | 0.51 ± 0.10 | -7.0 ± 0.2 | 5.6 ± 0.1 | - | - | Not found |
| 10MO-5MS | 10 | 5 | 0 | 231 ± 154 | 0.44 ± 0.04 | -6.2 ± 0.3 | 5.7 ± 0.1 | - | - | Not found |
| 10MO-12MS | 10 | 12 | 0 | 324 ± 246 | 0.58 ± 0.04 | -4.6 ± 0.2 | 5.7 ± 0.1 | - | - | Not found |
| 10MO-8MS-0.2AMG | 10 | 8 | 0.2 | 215 ± 122 | 0.32 ± 0.02 | -6.1 ± 0.2 | 5.7 ± 0.1 | 99.24 ± 0.03 | 1.1 ± 0.00 | Not found |
Drop size represented the mean of Z-average with SD from particle size distribution histograms.
Phase separation of NEs that was observed after they were centrifuged at 5,000 rpm for 30 min.
Fig. 1TLC fingerprints: (a) Lane A: standard AMG, Lane I, II: crude extract of mangosteen fruit pericarps with- and without addition of AMG, respectively; (b) Lane B: standard AMG, Lane I-IV: extract fraction number 5–8, respectively.
Fig. 2FT-IR spectra: (a)–(I) standard AMG (II) obtained AMG, and (b) molecular structure of the obtained AMG.
Effect of sonication intensity on droplet size, PI and phase separation of 10MO-8MS (mean ± SD; n = 3).
| Sonication intensity (% amplitude) | Droplet size | PI | Phase separation |
|---|---|---|---|
| 10 | 279 ± 203 | 0.53 ± 0.01 | Not found |
| 20 | 212 ± 124 | 0.34 ± 0.02 | Not found |
| 30 | 210 ± 121 | 0.33 ± 0.01 | Not found |
Drop size represented the mean of Z-average with SD from particle size distribution histograms.
Phase separation of NEs that was observed after they were centrifuged at 5,000 rpm for 30 min.
Fig. 3TEM micrographs: (a) 10MO-8MS and (b) 10MO-8MS-0.2AMG.
Fig. 4Rheological properties of 10MO-8MS and 10MO-8MS-0.2AMG: (a) viscosity profiles; (b) flow curves.
Fig. 5Release profile of AMG from 10MO-8MS-0.2AMG (mean ± SD, n = 3): (a) cumulative drug released content against time during 0–480 min; (b) cumulative drug released content against time during 60–480 min.
Physicochemical properties and AMG content of 10MO-8MS-0.2AMG after storage at a room temperature (27 ± 1 °C) for 90 days and under a heating-cooling test (5 cycles) (mean ± SD; n = 3).
| Storage conditions | Droplet size | PI | Zeta potential (mV) | pH | Phase separation | AMG content (%w/w) |
|---|---|---|---|---|---|---|
| 1) Room temperature | ||||||
| Day 0 | 215 ± 122 | 0.32 ± 0.02 | -6.1 ± 0.2 | 5.7 ± 0.1 | Not found | 0.20 ± 0.00 |
| Day 30 | 209 ± 121 | 0.34 ± 0.03 | -6.3 ± 0.2 | 5.5 ± 0.2 | Not found | 0.20 ± 0.01 |
| Day 60 | 212 ± 124 | 0.30 ± 0.02 | -5.9 ± 0.5 | 5.8 ± 0.4 | Not found | 0.19 ± 0.01 |
| Day 90 | 214 ± 126 | 0.35 ± 0.03 | -6.2 ± 0.8 | 5.5 ± 0.4 | Not found | 0.19 ± 0.01 |
| 2) Heating-cooling test | 218 ± 129 | 0.35 ± 0.04 | -5.8 ± 0.5 | 5.8 ± 0.4 | Not found | 0.19 ± 0.00 |
Drop size represented the mean of Z-average with SD from particle size distribution histograms.
Phase separation of NEs that was observed after they were stored under two different storage conditions without centrifugation.
Fig. 6Cell viability (%) of HaCaT after exposure to 10MO-8MS and 10MO-8MS-0.2AMG at various concentrations (mean ± SD, n = 3) (*significantly different from others at a p-value < 0.05).
Diameter of inhibition zones (mean ± SD; n = 3).
| Test samples | Diameter of inhibition zones (mm) | |
|---|---|---|
| 10MO-8MS | 0.0 ± 0.0 | 0.0 ± 0.0 |
| 10MO-8MS-0.2AMG | 10.0 ± 0.0 | 7.3 ± 0.6 |